Cited by 38Telomeres, Telomerase, and SenescenceFrailty in Older AdultsGenetics, Aging, and Longevity in Model Organisms

Biomarkers of cellular senescence predict the onset of mobility disability and are reduced by physical activity in older adults

Open access
Fielding, Roger A, Atkinson, Elizabeth J, Aversa, Zaira, White, Thomas A, Heeren, Amanda A, Mielke, Michelle M, Cummings, Steven R, Pahor, Marco +2 more·2024·The Journals of Gerontology: Series A

Abstract

Studies in mice and cross-sectional studies in humans support the premise that cellular senescence is a contributing mechanism to age-associated deficits in physical function. We tested the hypotheses that circulating proteins secreted by senescent cells are (i) associated with the incidence of major mobility disability (MMD), the development of persistent mobility disability (PMMD), and decrements in physical functioning in older adults, and (ii) influenced by physical activity (PA). Using samples and data obtained longitudinally from the Lifestyle Interventions in Elders Study clinical trial, we measured a panel of 27 proteins secreted by senescent cells. Among 1 377 women and men randomized to either a structured PA intervention or a healthy aging (HA) intervention, we observed significant associations between several senescence biomarkers, most distinctly vascular endothelial growth factor A (VEGFA), tumor necrosis factor receptor 1 (TNFR1), and matrix metallopeptidase 7 (MMP7), and the onset of both MMD and PMMD. Moreover, VEGFA, GDF15, osteopontin, and other senescence biomarkers were associated with reductions in short physical performance battery scores. The change in senescence biomarkers did not differ between PA and HA participants. In the whole cohort, higher levels of PA were associated with significantly greater reductions in 10 senescence-related proteins at 12 and/or 24 months. These data reinforce cellular senescence as a contributing mechanism of age-associated functional decline and the potential for PA to attenuate this hallmark of aging. Clinical Trials Registration Number: NCT01072500

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glad257

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The introduction argues that senescent cells and their SASP products contribute to deficits in cognition and mobility.

    “Recent evidence suggests that the accumulation of senescent cells, which can release a variety of pro-inflammatory, apoptotic, and toxic by-products, called the senescence-associated secretory phenotype (SASP), is one of the drivers of deficits in both cognition11, 12, 13, 14, 15, 16 and mobility.7,17, 18, 19, 20, 21, 22”

    From A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease (2025) · cites this paper as [19]

    The Discussion links cellular senescence and SASP molecules to inflammation and impaired physical function, and reports associations between SASP biomarkers and mobility disability in older adults. The page 2 introductory passage also discusses mobility, but the passages found do not link senescence or SASP products to cognitive deficits. The claim is therefore supported for mobility, not cognition. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • There is emerging evidence that exercise increases mitochondrial biogenesis (PRT), oxidative metabolism (cycling-aerobic exercise), cellular senescence, and muscle oxidative capacity.

    “However, there is emerging evidence that exercise increases mitochondrial biogenesis (PRT) [654], oxidative metabolism (cycling-aerobic exercise [655]), cellular senescence [72,73], and muscle oxidative capacity [656] (as measured by phosphocreatine recovery rate constant (kPCr) using 31 P Magnetic Resonance Spectroscopy).”
  • Exercise increases mitochondrial biogenesis (PRT), oxidative metabolism (cycling-aerobic exercise), cellular senescence, and muscle oxidative capacity.

    “However, there is emerging evidence that exercise increases mitochondrial biogenesis (PRT) [654], oxidative metabolism (cycling-aerobic exercise [655]), cellular senescence [72,73], and muscle oxidative capacity [656] (as measured by phosphocreatine recovery rate constant (kPCr) using 31 P Magnetic Resonance Spectroscopy).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [31]31. Taylor DM. Americans with Disabilities 2014. Currrent Popula- tion Reports. Washington, DC: U.S. Census Bureau; 2018:70-152.

Cited by

Sorted by citations

Authors
Fielding, R. A., Atkinson, E. J., Aversa, Z., White, T. A., Heeren, A. A., Mielke, M. M., Cummings, S. R., Pahor, M., Leeuwenburgh, C., & LeBrasseur, N. K.
Affiliations
  • Tufts University (US)
  • Mayo Clinic (US)
  • Wake Forest University Health Sciences (US)
  • University of California, San Francisco (US)
  • University of Florida (US)
Corresponding author
LeBrasseur, Nathan K
Venue
The Journals of Gerontology: Series A
Published
2023-11-08
Volume
79
Issue
3
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W4388556609
Cited by
38
References
48
Citations by year
2026: 13 · 2025: 12 · 2024: 13
FWCI
6.71
Type
journal article
Language
en
Open access
Locations
  • The Journals of Gerontology Series A (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01 AG055529, R56 AG060907, P01 AG062413, U54 AG044170)
  • Glenn Foundation for Medical Research
  • Pritzker Foundation
  • U.S. Department of Agriculture (58-8050-9-004)
  • NIH Boston Claude D. Pepper Center (1P30AG031679)
  • NIH University of Florida Claude D. Pepper Center (P30AG028740)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
cellular senescence, senescence-associated secretory phenotype, mobility impairment, physical activity, older adults, physical function decline, VEGF-A, TNFR1, MMP-7, GDF15, osteopontin, Short Physical Performance Battery, healthy aging interventions, biomarkers
MeSH terms
Aged, Animals, Cross-Sectional Studies, Exercise Therapy, Female, Humans, Life Style, Male, Biomarkers, Cellular Senescence, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review